.svg)
About
Precision For Value is a leader in providing data-driven strategies that maximize the market potential of pharmaceutical products. With a focus on health economics, market access, and reimbursement, Precision For Value partners with clients to help substantiate their product’s value through strategic insights, tailored pricing approaches, and evidence-based positioning. Their expertise supports clients in navigating complex healthcare landscapes, ensuring that innovative treatments reach the patients who need them.
.webp)
The Challenge
Precision For Value, in collaboration with its client, embarked on positioning Ublituximab, an innovative therapeutic, in an increasingly competitive global marketplace. To successfully launch the product, it was essential to develop a strong positioning strategy that clearly communicated Ublituximab’s unique value to a diverse audience of payers, providers, regulators, and patients. Additionally, the challenge extended to designing a pricing strategy substantiated by solid marketplace data, evidence, and insights to ensure both market access and financial viability.
Our Approach
Our strategy centered on leveraging comprehensive market analysis to refine Ublituximab’s value proposition and inform its pricing structure. We began by assessing the competitive landscape, focusing on how Ublituximab’s clinical benefits compared with current treatments. Through rigorous data analysis and insights gathered from market trends, we identified key differentiators that would appeal to each stakeholder group. For payers, the focus was on cost-effectiveness and potential for improved patient outcomes. For providers, we highlighted the drug’s therapeutic advantages and streamlined administration protocols. We then developed evidence-based positioning that would resonate across the healthcare spectrum, emphasizing both Ublituximab’s clinical efficacy and its economic benefits. The pricing strategy was tailored to reflect these insights, ensuring the product was positioned for optimal reimbursement potential in key markets.
Execution
Our team executed a series of data-driven strategies to substantiate Ublituximab’s value. We utilized real-world evidence and clinical trial data to build a compelling narrative around the drug’s efficacy and safety profile. Additionally, we conducted value assessments that focused on health economics and outcomes research (HEOR), enabling us to present a holistic picture of Ublituximab’s impact on patient care and healthcare costs. To solidify the pricing approach, we developed various scenarios and pricing models that demonstrated Ublituximab’s value relative to other therapies. By closely collaborating with Precision For Value’s in-house experts, we crafted a pricing framework that could adapt to regional market demands while ensuring global accessibility. This framework also provided actionable insights to support discussions with regulators and payers, ensuring they had the necessary data to make informed decisions on reimbursement and approval.
The Results
The strategic approach to Ublituximab’s positioning and pricing led to a successful reception among key healthcare stakeholders. Global payers and providers recognized the drug's clinical benefits, and our pricing strategy facilitated favorable reimbursement discussions in priority markets. This comprehensive approach helped establish Ublituximab as a valuable therapeutic option, supported by a clear economic rationale that reinforced its role in improving patient outcomes. The project underscored the importance of data-driven strategies in maximizing a product’s market potential while addressing the needs of both the healthcare system and patients.
.webp)
.svg)
